Michael Gray
2018 - X4 Pharmaceuticals
In 2018, Michael Gray earned a total compensation of $2.9M as Former President, Chief Executive Officer and Chief Financial Officer at X4 Pharmaceuticals, a 242% increase compared to previous year.
Compensation breakdown
| Bonus | $181,136 |
|---|---|
| Option Awards | $1,310,947 |
| Salary | $405,193 |
| Stock Awards | $1,030,000 |
| Total | $2,927,276 |
Gray received $1.3M in option awards, accounting for 45% of the total pay in 2018.
Gray also received $181.1K in bonus, $405.2K in salary and $1M in stock awards.
Rankings
In 2018, Michael Gray's compensation ranked 3,967th out of 14,244 executives tracked by ExecPay. In other words, Gray earned more than 72.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,967 out of 14,244 | 72nd |
Division Manufacturing | 1,460 out of 5,762 | 75th |
Major group Chemicals And Allied Products | 518 out of 2,125 | 76th |
Industry group Drugs | 435 out of 1,814 | 76th |
Industry Biological Products, Except Diagnostic Substances | 90 out of 339 | 74th |
Source: SEC filing on May 22, 2019.
Gray's colleagues
We found five more compensation records of executives who worked with Michael Gray at X4 Pharmaceuticals in 2018.
2018
René BCPS
X4 Pharmaceuticals
Chief Executive Officer
2018
Christopher Stevens
X4 Pharmaceuticals
Chief Medical Officer
2018
David Mantus
X4 Pharmaceuticals
Former Chief Development Officer
2018
Paula Ragan
X4 Pharmaceuticals
Chief Executive Officer
2018
Adam Mostafa
X4 Pharmaceuticals